Arunjyoti Bio

how big is Arunjyoti Bio?

As of Jun 06, Arunjyoti Bio Ventures Ltd has a market capitalization of 137.00 Cr, classifying it as a Micro Cap company, with recent net sales of 0.38 Cr and net profit of 0.10 Cr. Shareholder's funds are reported at 1.81 Cr, and total assets amount to 2.22 Cr.

Market Cap: As of Jun 06, Arunjyoti Bio Ventures Ltd has a market capitalization of 137.00 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 0.38 Cr and the sum of Net Profit is 0.10 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'10. The Shareholder's Funds are reported at 1.81 Cr, and the Total Assets amount to 2.22 Cr.

Has Arunjyoti Bio declared dividend?

No Dividend History Available

Who are the peers of the Arunjyoti Bio?

Arunjyoti Bio's peers include Bajaj Finance, Jio Financial, Cholaman.Inv.&Fn, Shriram Finance, Muthoot Finance, Thacker & Co., Tilak Ventures, Delphi World, and Landmarc Leisur. In terms of performance, Bajaj Finance leads with a 1-year return of 30.40%, while Arunjyoti Bio has a return of 4.31%.

Peers: The peers of Arunjyoti Bio are Bajaj Finance, Jio Financial, Cholaman.Inv.&Fn, Shriram Finance, Muthoot Finance, Thacker & Co., Tilak Ventures, Delphi World, Landmarc Leisur.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bajaj Finance, Cholaman.Inv.&Fn, and Muthoot Finance, while Average management risk is found at Jio Financial and Thacker & Co., and Below Average management risk is noted at Tilak Ventures, Delphi World, Landmarc Leisur., and Arunjyoti Bio. Growth is Excellent for Jio Financial and Arunjyoti Bio, Good for Bajaj Finance and Cholaman.Inv.&Fn, and Average for Tilak Ventures, while Below Average growth is seen at Thacker & Co. and Delphi World. Capital Structure is Excellent for Bajaj Finance, Jio Financial, Shriram Finance, and Muthoot Finance, Good for Thacker & Co., and Average for Arunjyoti Bio, with Below Average capital structure at Tilak Ventures, Delphi World, and Landmarc Leisur.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bajaj Finance at 30.40%, while the lowest is Jio Financial at -20.23%. Arunjyoti Bio's 1-year return is 4.31%, which is significantly higher than Jio Financial's but lower than Bajaj Finance's. Additionally, the six-month returns for Jio Financial, Thacker & Co., Tilak Ventures, Delphi World, and Landmarc Leisur. are negative.

Is Arunjyoti Bio overvalued or undervalued?

As of March 21, 2024, Arunjyoti Bio is considered very expensive with a PE ratio of -75.77 and unfavorable financial metrics, significantly underperforming against peers and the Sensex.

As of 21 March 2024, the valuation grade for Arunjyoti Bio has moved from risky to very expensive. This indicates a significant shift in perception, suggesting that the company is now considered overvalued. The current PE ratio stands at -75.77, while the EV to EBITDA ratio is 32.86, and the Price to Book Value is 4.28. These ratios highlight a concerning financial position, particularly with a negative ROE of -5.65% and a low ROCE of 3.38%.<BR><BR>In comparison to its peers, Arunjyoti Bio's valuation metrics are starkly unfavorable. For instance, Life Insurance has a PE ratio of 12.54 and an EV to EBITDA of 9.89, both indicating a more reasonable valuation. Similarly, Bajaj Finance, categorized as very expensive, has a PE ratio of 35.01, which still pales in comparison to Arunjyoti Bio's negative valuation metrics. The company's stock has underperformed significantly against the Sensex, particularly year-to-date with a decline of 63.28% compared to the Sensex's gain of 5.62%. Overall, Arunjyoti Bio appears to be overvalued given its financial ratios and peer comparisons.

What is the technical trend for Arunjyoti Bio?

As of April 30, 2025, Arunjyoti Bio's technical trend has shifted to bearish, supported by bearish signals from the MACD, Bollinger Bands, and moving averages, indicating a weak bearish sentiment in the market.

As of 30 April 2025, the technical trend for Arunjyoti Bio has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from the weekly MACD and Bollinger Bands, both signaling bearish conditions. The daily moving averages also confirm a bearish trend. The KST on a weekly basis is bearish, while the monthly KST remains mildly bearish. Dow Theory reflects a mildly bearish stance on the weekly and monthly time frames. Overall, the indicators suggest a weak bearish sentiment in the market for Arunjyoti Bio.

Who are in the management team of Arunjyoti Bio?

As of March 2022, the management team of Arunjyoti Bio includes Polsani Venkata Rama Rao (Non-Executive & Independent Director), Raja Kumar Babulal (Whole-time Director), Pabbathi Praveen Kumar (Whole Time Director & CFO), M Aditya Vardhan Reddy, D Vanaja Kumari, and K Chandra Sekhar (all Non-Executive & Independent Directors), along with Swati Jain (Company Secretary & Compliance Officer). The team consists of both executive and non-executive members.

As of March 2022, the management team of Arunjyoti Bio includes the following members:<BR><BR>1. Polsani Venkata Rama Rao - Non-Executive & Independent Director<BR>2. Raja Kumar Babulal - Whole-time Director<BR>3. Pabbathi Praveen Kumar - Whole Time Director & CFO<BR>4. M Aditya Vardhan Reddy - Non-Executive & Independent Director<BR>5. D Vanaja Kumari - Non-Executive & Independent Director<BR>6. K Chandra Sekhar - Non-Executive & Independent Director<BR>7. Swati Jain - Company Secretary & Compliance Officer<BR><BR>This team comprises a mix of executive and non-executive directors, along with a compliance officer.

What does Arunjyoti Bio do?

Arunjyoti Bio Ventures Ltd is a micro-cap NBFC specializing in co-packing services for beverages, with a market cap of INR 108 Cr. As of March 2025, it reported net sales of 53 Cr and a net loss of 20 Cr.

Overview:<BR>Arunjyoti Bio Ventures Ltd is a micro-cap company in the Non-Banking Financial Company (NBFC) sector, specializing in high-quality co-packing services for beverages.<BR><BR>History:<BR>Established in 1986, Arunjyoti Bio Ventures Ltd was formerly known as Century 21st Portfolio Limited. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 53 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -20 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 108 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.81<BR>- Return on Equity: -5.65%<BR>- Price to Book: 3.33<BR><BR>Contact Details:<BR>Address: Plot No 45 P&T Colony, Karkhana Secunderabad Telangana : 500009<BR>Tel: 91-44-66684223<BR>Email: cenport@gmail.com<BR>Website: http://www.century21st.in

Who are the top shareholders of the Arunjyoti Bio?

The top shareholders of Arunjyoti Bio are Dathvik Pabbhathi, the promoter with 23.07%, and public shareholder Chennupati Sarath Kumar with 13.14%. Individual investors hold a combined 49.59%, with no institutional or pledged promoter holdings.

The top shareholders of Arunjyoti Bio include Dathvik Pabbhathi, who is the promoter with the highest holding at 23.07%. The highest public shareholder is Chennupati Sarath Kumar, holding 13.14%. Additionally, individual investors collectively hold 49.59% of the shares. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings.

When is the next results date for Arunjyoti Bio?

The next results date for Arunjyoti Bio is November 3, 2025.

The next results date for Arunjyoti Bio is scheduled for November 3, 2025.

How has been the historical performance of Arunjyoti Bio?

Arunjyoti Bio's historical performance shows a decline in net sales from 0.43 crore in March 2010 to 0.08 crore in September 2010, but profitability metrics improved, with profit after tax rising from 0.03 crore to 0.04 crore and a significant increase in operating profit margin from 2.3% to 51.19%.

Answer:<BR>The historical performance of Arunjyoti Bio shows a modest growth in net sales and profitability over the reported periods.<BR><BR>Breakdown:<BR>In the financial results for the periods ending March 2010 and September 2010, Arunjyoti Bio reported net sales of 0.43 crore and 0.08 crore respectively, indicating a decline in total operating income from 0.43 crore in March 2010 to 0.08 crore in September 2010. The total expenditure, excluding depreciation, also decreased from 0.42 crore to 0.04 crore during the same period. Operating profit (PBDIT) showed a slight increase from 0.09 crore in March 2010 to 0.07 crore in September 2010, while profit before tax rose from 0.04 crore to 0.06 crore. Profit after tax also increased from 0.03 crore to 0.04 crore, reflecting a PAT margin of 50.0% in September 2010 compared to 6.67% in March 2010. The earnings per share (EPS) improved from 0.15 to 0.20, and the operating profit margin (excluding other income) significantly increased from 2.3% to 51.19%. Overall, while there was a decline in sales, the company managed to improve its profitability metrics in the latter period.

Are Arunjyoti Bio Ventures Ltd latest results good or bad?

Arunjyoti Bio Ventures Ltd's latest results show a mixed performance, with a net profit of ₹0.87 crores for FY26 but recent losses leading to a negative ROE of -6.76%. Concerns about overvaluation, significant stock underperformance, and low institutional interest suggest a cautious outlook despite some positive indicators.

The latest results for Arunjyoti Bio Ventures Ltd present a mixed picture. For the nine-month period of FY26, the company reported a net profit of ₹0.87 crores, which is a positive year-on-year improvement. However, the overall financial performance has been characterized by volatility and concerns regarding its valuation.<BR><BR>Key highlights include a strong return on equity (ROE) of 29.81%, indicating effective capital utilization when the company is profitable. However, this is contrasted by a recent negative ROE of -6.76%, suggesting losses in the most recent period, which raises concerns about the sustainability of its profitability.<BR><BR>On the valuation front, the company trades at a price-to-book value of 3.94x, which is considered a premium and raises questions about whether the stock is overvalued given its modest operational scale and inconsistent profitability. The Mojo Score of 16 out of 100 indicates a "Strong Sell" rating, reflecting poor performance across various metrics.<BR><BR>Additionally, the stock has severely underperformed over the past year, declining by 49.66%, while the broader market has gained. This underperformance, combined with zero institutional interest and a significant reduction in promoter holding, adds to the concerns surrounding the company's future prospects.<BR><BR>In summary, while there are some positive aspects, such as the recent profit and strong historical ROE, the overall outlook is cautious due to valuation concerns, recent losses, and significant stock underperformance.

Should I buy, sell or hold Arunjyoti Bio Ventures Ltd?

Which are the latest news on Arunjyoti Bio?

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 17-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising to 7.12, reflecting a 7.72% increase today. However, the stock has a year-to-date decline of 15.74% and is trading below its moving averages, indicating ongoing challenges and reduced investor interest.

As of 17-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising, currently at 7.12, with a change of 0.51, representing an increase of 7.72%. This rise can be attributed to the stock's performance today, where it has outperformed its sector by 6.92% and has gained consecutively for the last two days, resulting in an overall return of 8.37% during this period. <BR><BR>Despite this recent upward movement, it is important to note that the stock has been underperforming over longer periods, with a year-to-date decline of 15.74% and a significant drop of 54.03% over the past year. Additionally, the stock is currently trading below its moving averages across various time frames, indicating a potential bearish trend. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 63.1% compared to the 5-day average. <BR><BR>In summary, while Arunjyoti Bio Ventures Ltd is experiencing a short-term rise in stock price, the broader context reveals ongoing challenges and a lack of sustained investor interest.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 18-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising to 7.81, reflecting a 9.69% increase. However, despite recent gains, the stock has a year-to-date decline of 7.57% and a 50.32% drop over the past year, indicating long-term performance concerns.

As of 18-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising, currently at 7.81, reflecting a change of 0.69 or 9.69% increase. This upward movement can be attributed to several factors. The stock has outperformed its sector by 8.34% today and has shown a consecutive gain over the last three days, with a total return of 18.87% during this period. Additionally, the stock has performed well over the past week, with a 10.62% increase, contrasting sharply with the Sensex, which has seen a slight decline of 0.21%.<BR><BR>Despite these positive short-term trends, it is important to note that the stock has experienced significant declines over the longer term, with a year-to-date drop of 7.57% and a staggering 50.32% decrease over the past year. The stock's performance has also been hindered by a negative return on equity of -3.3 and a high price-to-book value of 4.3, indicating an expensive valuation compared to its peers. Furthermore, the delivery volume has decreased by 11.49% against the five-day average, suggesting a decline in investor participation.<BR><BR>In summary, while Arunjyoti Bio Ventures Ltd is currently experiencing a rise in stock price due to recent gains and sector outperformance, its long-term performance remains concerning, characterized by significant losses and underperformance relative to the broader market.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 19-Mar, Arunjyoti Bio Ventures Ltd's stock price is at 7.07, reflecting a 9.59% decline after three days of gains, indicating a trend reversal. The stock has underperformed its sector and shows significant year-to-date and annual decreases, despite strong long-term performance.

As of 19-Mar, Arunjyoti Bio Ventures Ltd's stock price is falling, currently at 7.07, which reflects a decrease of 0.75 or 9.59%. This decline is notable as it comes after three consecutive days of gains, indicating a trend reversal. The stock has underperformed its sector by 5.75% today, and the broader finance/NBFC sector has also experienced a decline of 3.85%. <BR><BR>In terms of performance over various periods, the stock has shown a year-to-date decrease of 16.33% and a significant drop of 53.30% over the past year, contrasting sharply with its impressive long-term performance of +149.71% over three years and +5810.55% over five years. <BR><BR>Additionally, while the stock's delivery volume has increased significantly by 145.31% compared to the five-day average, indicating rising investor participation, the stock remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the short to medium term. Overall, these factors contribute to the current downward movement in the stock price of Arunjyoti Bio Ventures Ltd.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 20-Mar, Arunjyoti Bio Ventures Ltd's stock price is at 7.01, reflecting a 0.85% decrease and a 10.36% loss over the last two days. The stock is underperforming, trading below all key moving averages, and experiencing significantly reduced investor participation, indicating a lack of confidence.

As of 20-Mar, Arunjyoti Bio Ventures Ltd's stock price is falling, currently at 7.01, which reflects a decrease of 0.06 or 0.85%. The stock has been underperforming recently, having lost 10.36% over the last two days, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, investor participation has decreased significantly, with delivery volume on 19 March falling by 41.33% compared to the 5-day average. This decline in trading activity suggests a lack of investor confidence, contributing to the stock's downward trend. Overall, these factors indicate that Arunjyoti Bio Ventures Ltd is experiencing a decline in its stock price.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 23-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising to 7.49, reflecting a 6.85% increase due to a trend reversal after previous declines. Despite a year-to-date drop of 11.36%, recent performance shows resilience, outperforming its sector and indicating short-term bullish sentiment, though declining investor participation suggests caution.

As of 23-Mar, Arunjyoti Bio Ventures Ltd's stock price is rising, currently at 7.49, reflecting an increase of 0.48 or 6.85%. This upward movement can be attributed to a trend reversal, as the stock has gained after two consecutive days of decline. Additionally, it has outperformed its sector by 10.65%, indicating stronger performance relative to the broader market context. <BR><BR>Despite a year-to-date decline of 11.36% and a significant drop of 47.44% over the past year, the stock's recent performance shows resilience, particularly over the past week, where it has increased by 13.31% while the Sensex has fallen by 3.72%. The stock is currently trading above its 5-day, 20-day, and 50-day moving averages, which may suggest a short-term bullish sentiment among investors. However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 75.69% against the 5-day average, which could indicate caution among some investors. Overall, the combination of a recent trend reversal and relative outperformance in the sector contributes to the stock's rising price.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 24-Mar, Arunjyoti Bio Ventures Ltd's stock price is declining, currently at 6.87, reflecting an 8.03% decrease. The stock has significantly underperformed against the Sensex, with notable declines over various time frames and a bearish trend indicated by its moving averages.

As of 24-Mar, Arunjyoti Bio Ventures Ltd's stock price is falling, currently at 6.87, which reflects a decrease of 0.6 or 8.03%. The stock has underperformed significantly compared to the benchmark Sensex, with a one-week decline of 3.51% versus the Sensex's 2.63% drop, and a one-month decline of 11.24% compared to the Sensex's 9.92%. Year-to-date, the stock has fallen by 18.70%, while the Sensex has decreased by 13.09%. Over the past year, the stock has experienced a substantial decline of 52.69%, contrasting sharply with the Sensex's modest 5.02% decline.<BR><BR>Additionally, the stock is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Despite a notable increase in delivery volume, which rose by 101.27% against the 5-day average, the overall performance today has underperformed the sector by 10.35%. This combination of factors contributes to the ongoing decline in the stock price of Arunjyoti Bio Ventures Ltd.

Why is Arunjyoti Bio Ventures Ltd falling/rising?

As of 25-Mar, Arunjyoti Bio Ventures Ltd's stock price is declining at 6.25, down -8.49%, significantly underperforming the Sensex. The stock has fallen for two consecutive days and is trading below all moving averages, indicating a bearish trend despite increased investor participation.

As of 25-Mar, Arunjyoti Bio Ventures Ltd is experiencing a decline in its stock price, currently at 6.25, which reflects a change of -0.58 or -8.49%. The stock has underperformed significantly compared to the benchmark Sensex, which has only decreased by -1.87% over the past week. Over the last month, Arunjyoti Bio has dropped -16.78%, while the Sensex has fallen by -8.51%. Year-to-date, the stock is down -26.04%, compared to the Sensex's -11.67% decline.<BR><BR>The stock has been on a downward trend, having fallen for the last two consecutive days, resulting in a total loss of -16.33% during this period. Additionally, it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish sentiment. <BR><BR>Despite a notable increase in investor participation, with delivery volume rising by 222.8% against the 5-day average, the overall performance today shows that the stock has underperformed its sector by -11.41%. This combination of factors contributes to the current decline in Arunjyoti Bio Ventures Ltd's stock price.